Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
Sponsor: October 6 University
Summary
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM
Official title: Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome: A Randomized Clinical Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-11-25
Completion Date
2026-02-01
Last Updated
2025-07-30
Healthy Volunteers
No
Conditions
Interventions
Metformin Hydrochloride tablet
Metformin Hydrochloride 850 mg oral tablet
Vildagliptin 50 MG
Vildagliptin 50 MG oral tablets
Locations (1)
October 6 university hospital
Giza, Egypt